Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market Size study & Forecast, by Product (Cardiac Monitoring Devices, Cardiac Rhythm Management Devices) by End Use and Regional Forecasts 2025-2035

The Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market, valued at USD 21.84 billion in 2024, is poised to expand at a steady CAGR of 4.45% during 2025–2035, underpinned by the escalating global prevalence of cardiovascular diseases, advancements in diagnostic and therapeutic technologies, and the increasing adoption of preventive healthcare measures. These devices—ranging from wearable cardiac monitors and implantable loop recorders to advanced pacemakers and defibrillators—play an indispensable role in diagnosing arrhythmias, monitoring cardiac health, and restoring normal heart rhythm. With aging populations, rising obesity rates, and lifestyle-related risk factors intensifying the global cardiovascular burden, the demand for accurate, real-time cardiac monitoring and effective rhythm management solutions is surging across hospital, ambulatory, and homecare settings.

The rising incidence of cardiac disorders has catalyzed significant investment in next-generation devices that offer greater accuracy, remote monitoring capabilities, and enhanced patient comfort. According to the World Health Organization, cardiovascular diseases remain the leading cause of mortality worldwide, accounting for nearly 17.9 million deaths annually. This alarming figure has prompted healthcare providers and policymakers to intensify early detection efforts and expand access to advanced cardiac care. Furthermore, technological breakthroughs—such as AI-enabled diagnostic algorithms, minimally invasive implantable devices, and Bluetooth-enabled portable monitors—are revolutionizing the patient experience, enabling clinicians to track and respond to cardiac events with unprecedented speed and precision. While high device costs and reimbursement challenges in certain regions may temper growth, the expanding scope of telecardiology and integration of cardiac devices into broader digital health ecosystems present promising avenues for market expansion.

From a geographical perspective, North America currently dominates the market, bolstered by robust healthcare infrastructure, a high prevalence of heart disease, and strong adoption of advanced cardiac care technologies. The U.S. leads the region with a mature ecosystem of medical device manufacturers, favorable reimbursement frameworks, and a strong culture of preventive healthcare. Europe follows closely, supported by government-backed screening programs, rising geriatric populations, and a strong regulatory environment ensuring device efficacy and safety. Meanwhile, the Asia Pacific region is expected to register the fastest growth through 2035, fueled by rapid urbanization, growing healthcare investments, and increasing cardiovascular disease awareness in countries such as China and India. This growth is further amplified by improving access to healthcare, strategic collaborations between global device manufacturers and local healthcare providers, and the discovery of underserved patient segments in emerging economies.

Major market players included in this report are:
• Medtronic plc
• Abbott Laboratories
• Boston Scientific Corporation
• GE Healthcare
• Philips Healthcare
• Biotronik SE & Co. KG
• Nihon Kohden Corporation
• Zoll Medical Corporation
• Schiller AG
• LivaNova PLC
• Asahi Kasei Corporation
• Hillrom (Baxter International Inc.)
• Lepu Medical Technology Co., Ltd.
• MicroPort Scientific Corporation
• Shenzhen Mindray Bio-Medical Electronics Co., Ltd.

Global Cardiac Monitoring & Cardiac Rhythm Management Devices Market Report Scope:
• Historical Data – 2023, 2024
• Base Year for Estimation – 2024
• Forecast period – 2025-2035
• Report Coverage – Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
• Regional Scope – North America; Europe; Asia Pacific; Latin America; Middle East & Africa



The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values for the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within the countries involved in the study. The report also provides detailed information about crucial aspects, such as driving factors and challenges, which will define the future growth of the market. Additionally, it incorporates potential opportunities in micro-markets for stakeholders to invest, along with a detailed analysis of the competitive landscape and product offerings of key players.

The detailed segments and sub-segments of the market are explained below:

By Product:
• Cardiac Monitoring Devices
• Cardiac Rhythm Management Devices

By End Use:
• Hospitals
• Ambulatory Care Centers
• Homecare Settings

By Region:

North America
• U.S.
• Canada

Europe
• UK
• Germany
• France
• Spain
• Italy
• ROE

Asia Pacific
• China
• India
• Japan
• Australia
• South Korea
• RoAPAC

Latin America
• Brazil
• Mexico

Middle East & Africa
• UAE
• Saudi Arabia
• South Africa
• Rest of Middle East & Africa

Key Takeaways:
• Market Estimates & Forecast for 10 years from 2025 to 2035.
• Annualized revenues and regional level analysis for each market segment.
• Detailed analysis of geographical landscape with Country level analysis of major regions.
• Competitive landscape with information on major players in the market.
• Analysis of key business strategies and recommendations on future market approach.
• Analysis of competitive structure of the market.
• Demand side and supply side analysis of the market.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions. Show more